{
  "drugs": [
    {
      "id": "levodopa",
      "name": "Levodopa",
      "therapeutic_area": "Parkinson’s Disease",
      "mechanism": "Dopamine precursor; converted in CNS",
      "target": "DOPA decarboxylase pathway",
      "sar": "Catechol + amino acid backbone required",
      "metabolism": "Peripheral decarboxylation unless paired with carbidopa",
      "pk": "Short half-life; crosses BBB via amino acid transporter",
      "ddis": "High-protein meals reduce absorption",
      "clinical": "Gold standard for motor symptoms"
    },
    {
      "id": "carbamazepine",
      "name": "Carbamazepine",
      "therapeutic_area": "Epilepsy (Focal Seizures)",
      "mechanism": "Use-dependent Na⁺ channel blocker",
      "target": "Voltage-gated sodium channels",
      "sar": "Tricyclic scaffold important for activity",
      "metabolism": "CYP3A4 → active epoxide metabolite; autoinduction",
      "pk": "Highly lipophilic; induces metabolism of other drugs",
      "ddis": "Strong CYP inducer (↓ warfarin, OCs)",
      "clinical": "Effective but requires monitoring"
    }
  ]
}
